Kala Pharmaceuticals

BiotechnologySeries CWaltham, USkalarx.com

Latest round

Series C

Last raised

Apr 2016

Total raised

$105M

Investors

12

About Kala Pharmaceuticals

Kala Pharmaceuticals, Inc., founded in 2009 and headquartered in Waltham, US, specializes in ophthalmic therapies. The company transitioned its business model after selling its previously commercialized products to Alcon Inc. in July 2022.00 mn.Kala Pharmaceuticals specializes in innovative therapies targeting rare and serious eye diseases. Its flagship product, KPI-012, is in Phase 2b clinical trials for persistent corneal epithelial defect (PCED), and is also being evaluated for other ocular conditions. Furthermore, the company is developing an intravitreal therapy in preclinical stages, aimed at inherited retinal degenerations and other back-of-the-eye diseases.72 mn. They also aim to explore new geographic markets, although specific regions have not been disclosed.

Who invested in Kala Pharmaceuticals

12 investors across 5 rounds

See all investors in Kala Pharmaceuticals

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Apr 13, 2016

    Amount

    $68M

    Investors

    Locked

  2. Series B

    Apr 16, 2014

    Amount

    $23M

    Investors

    Locked

  3. Series A

    Feb 14, 2013

    Amount

    $5.8M

    Investors

    Locked

  4. Seed

    Feb 29, 2012

    Amount

    $6.2M

    Investors

    Locked

  5. Seed

    Oct 26, 2010

    Amount

    $3M

    Investors

    Locked

Questions about Kala Pharmaceuticals

Who invested in Kala Pharmaceuticals?

Kala Pharmaceuticals has 12 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Kala Pharmaceuticals raised?

Kala Pharmaceuticals has raised 5 venture rounds. Sign up free to see how much each round raised and the total.

When did Kala Pharmaceuticals last raise money?

Kala Pharmaceuticals's most recent round on record is a Series C, in Apr 2016.

What does Kala Pharmaceuticals do?

Kala Pharmaceuticals is a biotechnology company.

Where is Kala Pharmaceuticals headquartered?

Kala Pharmaceuticals is headquartered in Waltham, US.

Which VCs invest in companies like Kala Pharmaceuticals?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Kala Pharmaceuticals's stage. Their profiles are linked below.

Raising like Kala Pharmaceuticals? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.